Selecta Biosciences, Inc. (SELB) Q3 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the Selecta Biosciences third quarter 2021 financial results and corporate update conference call. Currently, all participants are in a listen-only mode. This call is being webcast live on investors and media section of Selecta's website at www.selectabio.com, and it is being recorded. For opening remarks, I would like to introduce Kevin Tan, Chief Financial Officer of Selecta. Please go ahead. Thank you and good morning. Welcome to our third quarter 2021 financial results and corporate update conference call. The press release reporting our financial results is available in the investors and media section of Selective's website, www.selectivebio.com. And the quarterly report on Form 10Q ended September 30th, 2021, which was filed today with the Securities and Exchange Commission, or SEC. Joining me today are Carson Bruhn, President and Chief Executive Officer, Peter Traber, Chief Medical Officer, and Kay Kishimoto, Chief Scientific Officer. During today's call, we will be making certain forward-looking statements, including without limitation, statements about the potential safety, efficacy, and regulatory and clinical progress of our product candidates, financial projections, in our future expectations, plans, partnerships, and prospects. These statements are subject to various risks that are described in the filings made with the SEC, including the most recent quarterly report on Form 10Q. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today, November 9th, 2021, and selected disclaims any obligation to update such statements, even if management's views change. I would now like to turn the call over to Carson Brunn. Carson? Thank you, Kevin. Good morning. I appreciate everyone j...